BioCentury | Feb 3, 2014
Company News

Galectin Therapeutics, SBH Sciences deal

...to disclose details, and SBH could not be reached. Galectin Therapeutics Inc. (NASDAQ:GALT), Norcross, Ga. SBH Sciences Inc....
BioCentury | Jun 20, 2012
Company News

Massachusetts, Israel announce first round of joint R&D projects

...a total of $1.3 million for the projects. Biotech-related projects include a collaboration between CRO SBH Sciences...
BioCentury | Dec 3, 2007
Company News

Meristem, SBH Sciences Inc. deal

...are growth factors and hormones. Further terms were not disclosed. Meristem Therapeutics , Clermont-Ferrand, France SBH Sciences Inc....
Items per page:
1 - 3 of 3
BioCentury | Feb 3, 2014
Company News

Galectin Therapeutics, SBH Sciences deal

...to disclose details, and SBH could not be reached. Galectin Therapeutics Inc. (NASDAQ:GALT), Norcross, Ga. SBH Sciences Inc....
BioCentury | Jun 20, 2012
Company News

Massachusetts, Israel announce first round of joint R&D projects

...a total of $1.3 million for the projects. Biotech-related projects include a collaboration between CRO SBH Sciences...
BioCentury | Dec 3, 2007
Company News

Meristem, SBH Sciences Inc. deal

...are growth factors and hormones. Further terms were not disclosed. Meristem Therapeutics , Clermont-Ferrand, France SBH Sciences Inc....
Items per page:
1 - 3 of 3